We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$735M
AUM Growth
+$91.2M
Cap. Flow
+$63.4M
Cap. Flow %
8.63%
Top 10 Hldgs %
24.07%
Holding
118
New
17
Increased
44
Reduced
5
Closed
14

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$14.4M
2
SYNA icon
Synaptics
SYNA
+$9.97M
3
DATA
Tableau Software, Inc.
DATA
+$9.41M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$4.8M
5
AKBA icon
Akebia Therapeutics
AKBA
+$4M

Top Sells

Rank Stock Value
1
PBYI icon
Puma Biotechnology
PBYI
+$4.68M
2
SJM icon
J.M. Smucker
SJM
+$4.51M
3
NOV icon
NOV
NOV
+$3.7M
4
PCYC
PHARMACYCLICS INC
PCYC
+$2.7M
5
ECYT
Endocyte, Inc. Common Stock
ECYT
+$2.33M

Sector Composition

Rank Sector Weight
1 Healthcare 26.56%
2 Technology 14.37%
3 Consumer Discretionary 13.18%
4 Industrials 9.24%
5 Materials 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGIO icon
1
Agios Pharmaceuticals
AGIO
$1.95B
$22.5M 3.06%
490,500
+36,300
+8% +$1.48M
MDVN
2
DELISTED
MEDIVATION, INC.
MDVN
$21.2M 2.89%
550,600
+21,600
+4% +$728K
TRW
3
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
$17.8M 2.42%
198,400
– –
PANW icon
4
Palo Alto Networks
PANW
$265B
$17.2M 2.34%
1,233,600
– –
EOG icon
5
EOG Resources
EOG
$77.5B
$16.9M 2.3%
144,800
– –
ABBV icon
6
AbbVie
ABBV
$455B
$16.5M 2.25%
292,700
+4,900
+2% +$257K
SUNE
7
DELISTED
SUNEDISON, INC COM
SUNE
$16.5M 2.24%
729,100
– –
CELG
8
DELISTED
Celgene Corp
CELG
$16.3M 2.22%
+190,000
New +$14.4M
MGA icon
9
Magna International
MGA
$19B
$16.1M 2.19%
299,400
– –
MIC
10
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$15.9M 2.16%
255,200
– –
WBC
11
DELISTED
WABCO HOLDINGS INC.
WBC
$15.7M 2.14%
147,100
+18,700
+15% +$2M
RHT
12
DELISTED
Red Hat Inc
RHT
$14.8M 2.01%
267,600
+35,300
+15% +$1.8M
LEA icon
13
Lear
LEA
$7.33B
$14.4M 1.95%
160,900
– –
LLTC
14
DELISTED
Linear Technology Corp
LLTC
$13.8M 1.87%
292,600
+19,400
+7% +$899K
SYNA icon
15
Synaptics
SYNA
$4.25B
$13.3M 1.81%
+147,100
New +$9.97M
CBI
16
DELISTED
Chicago Bridge & Iron Nv
CBI
$13.2M 1.8%
193,800
– –
ROC
17
DELISTED
ROCKWOOD HLDGS INC
ROC
$12.9M 1.76%
170,400
– –
DYAX
18
DELISTED
DYAX CORPORATION
DYAX
$12.8M 1.74%
1,330,400
+52,400
+4% +$399K
TEX icon
19
Terex
TEX
$7.11B
$12.5M 1.7%
303,500
– –
MEOH icon
20
Methanex
MEOH
$4.27B
$12.4M 1.69%
201,300
– –
FPRX
21
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$12M 1.64%
773,600
+260,400
+51% +$3.73M
WAB icon
22
Wabtec
WAB
$49.4B
$12M 1.63%
144,700
+9,000
+7% +$694K
STKL
23
DELISTED
SunOpta
STKL
$11.8M 1.6%
834,600
+12,000
+1% +$149K
LOW icon
24
Lowe's Companies
LOW
$118B
$11.6M 1.58%
242,400
– –
CPN
25
DELISTED
Calpine Corporation
CPN
$11.4M 1.54%
477,100
+53,000
+12% +$1.2M
1
2 3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2014 Portfolio in Review

As of Q2 2014, Eventide Asset Management held 118 positions worth $735M, up 14% from $644M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management deployed $63.4M of net new capital in Q2 2014, opening 17 new positions and adding to 44 existing holdings. Its largest new stake was Celgene Corp: 190,000 shares worth $16.3M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was PHARMACYCLICS INC, an estimated $2.7M trimmed.

  • Eventide Asset Management's largest Q2 2014 buy was Celgene Corp: 190,000 shares worth $16.3M.
  • Eventide Asset Management added most to Acadia Pharmaceuticals in Q2 2014, an estimated $4.8M increase.
  • Eventide Asset Management's biggest Q2 2014 reduction was PHARMACYCLICS INC, cutting an estimated $2.7M.
  • Eventide Asset Management fully exited Puma Biotechnology in Q2 2014, selling an estimated $4.68M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $735M portfolio in Q2 2014.
  • Eventide Asset Management opened 17 new positions and closed 14 in Q2 2014.
  • Eventide Asset Management's portfolio value rose 14% quarter-over-quarter to $735M.

Based on Eventide Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.